2020
DOI: 10.1002/14651858.cd008227.pub4
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Pancreatic enzyme replacement therapy for people with cystic fibrosis

Search citation statements

Order By: Relevance

Paper Sections

Select...
38
5
4
0

Citation Types

0
28
0
8

Year Published

Range
2021
2021
2026
2026

Publication Types

Select...
46

Relationship

0
46

Authors

Journals

citations

Cited by 45 publications

(36 citation statements)
references

References 101 publications

0
28
0
8
Order By: Relevance
How this paper cites the one you are viewing
“…41 In patients with CF, improvement in nutritional status has often been demonstrated to be a primary outcome parameter. 113 Long-term studies on PERT demonstrated clinically relevant and statistically significant improvements in nutritional parameters, including body weight and PEI-related symptoms, after 6-12 months. 88,[114][115][116] Some patients may experience symptoms of maldigestion with PERT, but there is a significant improvement in diarrhea, steatorrhea, weight loss, recurrent pain, and the overall QoL.…”
Section: Level Of Evidence: 5; Percentage Of Agreement: 976%
mentioning
confidence: 90%